rs61755630
Variant names:
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_032387.5(WNK4):c.3432-20T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00301 in 1,614,020 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0024 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0031 ( 10 hom. )
Consequence
WNK4
NM_032387.5 intron
NM_032387.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.17
Publications
1 publications found
Genes affected
WNK4 (HGNC:14544): (WNK lysine deficient protein kinase 4) This gene encodes a member of the WNK family of serine-threonine protein kinases. The kinase is part of the tight junction complex in kidney cells, and regulates the balance between NaCl reabsorption and K(+) secretion. The kinase regulates the activities of several types of ion channels, cotransporters, and exchangers involved in electrolyte flux in epithelial cells. Mutations in this gene result in pseudohypoaldosteronism type IIB.[provided by RefSeq, Sep 2009]
COA3 (HGNC:24990): (cytochrome c oxidase assembly factor 3) This gene encodes a member of the cytochrome c oxidase assembly factor family. Studies of a related gene in fly suggest that the encoded protein is localized to mitochondria and is essential for cytochrome c oxidase function. [provided by RefSeq, Nov 2012]
COA3 Gene-Disease associations (from GenCC):
- cytochrome-c oxidase deficiency diseaseInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- mitochondrial diseaseInheritance: AR Classification: LIMITED Submitted by: ClinGen
- mitochondrial complex IV deficiency, nuclear type 14Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 17-42796103-T-C is Benign according to our data. Variant chr17-42796103-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 262025.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 359 AD gene.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| WNK4 | ENST00000246914.10 | c.3432-20T>C | intron_variant | Intron 16 of 18 | 1 | NM_032387.5 | ENSP00000246914.4 | |||
| WNK4 | ENST00000591448.5 | n.*1933-20T>C | intron_variant | Intron 15 of 17 | 1 | ENSP00000467088.1 | ||||
| COA3 | ENST00000586680.1 | n.*193A>G | non_coding_transcript_exon_variant | Exon 3 of 3 | 2 | ENSP00000467546.1 | ||||
| COA3 | ENST00000586680.1 | n.*193A>G | 3_prime_UTR_variant | Exon 3 of 3 | 2 | ENSP00000467546.1 |
Frequencies
GnomAD3 genomes AF: 0.00236 AC: 359AN: 152130Hom.: 0 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
359
AN:
152130
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00216 AC: 542AN: 251322 AF XY: 0.00230 show subpopulations
GnomAD2 exomes
AF:
AC:
542
AN:
251322
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00308 AC: 4496AN: 1461772Hom.: 10 Cov.: 35 AF XY: 0.00302 AC XY: 2196AN XY: 727196 show subpopulations
GnomAD4 exome
AF:
AC:
4496
AN:
1461772
Hom.:
Cov.:
35
AF XY:
AC XY:
2196
AN XY:
727196
show subpopulations
African (AFR)
AF:
AC:
19
AN:
33480
American (AMR)
AF:
AC:
102
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
AC:
7
AN:
26136
East Asian (EAS)
AF:
AC:
0
AN:
39700
South Asian (SAS)
AF:
AC:
45
AN:
86250
European-Finnish (FIN)
AF:
AC:
11
AN:
53310
Middle Eastern (MID)
AF:
AC:
27
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
4150
AN:
1112008
Other (OTH)
AF:
AC:
135
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
293
586
879
1172
1465
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
156
312
468
624
780
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00236 AC: 359AN: 152248Hom.: 0 Cov.: 32 AF XY: 0.00212 AC XY: 158AN XY: 74454 show subpopulations
GnomAD4 genome
AF:
AC:
359
AN:
152248
Hom.:
Cov.:
32
AF XY:
AC XY:
158
AN XY:
74454
show subpopulations
African (AFR)
AF:
AC:
37
AN:
41556
American (AMR)
AF:
AC:
22
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3468
East Asian (EAS)
AF:
AC:
0
AN:
5182
South Asian (SAS)
AF:
AC:
0
AN:
4818
European-Finnish (FIN)
AF:
AC:
1
AN:
10610
Middle Eastern (MID)
AF:
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
AC:
291
AN:
67990
Other (OTH)
AF:
AC:
3
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
19
37
56
74
93
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Oct 31, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Pseudohypoaldosteronism type 2B Benign:1
Aug 09, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.